<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">Endothelial dysfunction</z:e>, <z:mp ids='MP_0003674'>oxidative stress</z:mp> and systemic <z:mp ids='MP_0001845'>inflammation</z:mp> play an important role in the enhanced cardiovascular risk in <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Carotid intima-media thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>), a widely accepted marker of subclinical <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, is known to be increased in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The relationships between plasma markers of cardiac risk and carotid <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> are not well known </plain></SENT>
<SENT sid="3" pm="."><plain>We therefore studied a group of patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> to evaluate the relationships between plasma markers of cardiac risk and carotid <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>DESIGN AND PATIENTS: We measured carotid <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> and the levels of soluble endothelial <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules [sE-selectin, intercellular cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1 (sICAM-1) and vascular cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1 (sVCAM-1)], C-reactive protein (CRP) and <z:chebi fb="0" ids="33023">8-isoprostane</z:chebi> in 40 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> without clinical macrovascular complications (HbA1c&lt;10%, duration of <z:mp ids='MP_0002055'>diabetes</z:mp>&lt;12 years) and 25 healthy subjects </plain></SENT>
<SENT sid="5" pm="."><plain>We then examined the correlations between these plasma markers, carotid <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> and various clinical and biochemical parameters </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Diabetic patients had higher plasma sE-selectin (p=0.03), sICAM-1 (p=0.05), CRP (p=0.047) and <z:chebi fb="0" ids="33023">8-isoprostane</z:chebi> (p=0.001) concentrations than control subjects </plain></SENT>
<SENT sid="7" pm="."><plain>Mean <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> values were identical (0.63 +/- 0.02 mm) in diabetic (range, 0.40-0.92 mm) and healthy subjects (range, 0.45-0.85 mm) </plain></SENT>
<SENT sid="8" pm="."><plain>In diabetic patients, stepwise multivariate analysis showed that HbA1c and plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> were independent predictors of sE-selectin (r2=0.19 and r2=0.17, p&lt;0.01, respectively), whereas waist circumference and body mass index (BMI) were predictors of sICAM-1 (r2=0.27, p=0.001 and r2=0.22, p=0.002, respectively) </plain></SENT>
<SENT sid="9" pm="."><plain>Waist circumference was the only predictor of CRP (r2=0.2, p&lt;0.01), and systolic blood pressure was the only predictor of <z:chebi fb="0" ids="33023">8-isoprostane</z:chebi> (r2=0.19, p=0.006) </plain></SENT>
<SENT sid="10" pm="."><plain>In control subjects, similar analysis showed that plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> and waist circumference were predictors of sE-selectin and sICAM-1, respectively (r2=0.2, p&lt;0.05) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: These results indicate that some well-controlled type 2 diabetic patients free of clinical macrovascular complications have elevated plasma markers of cardiovascular risk without having increased <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>The elevation of plasma markers of endothelial cell activation (sE-selectin and s-ICAM-1) or <z:mp ids='MP_0001845'>inflammation</z:mp> (CRP) and <z:mp ids='MP_0003674'>oxidative stress</z:mp> (<z:chebi fb="0" ids="33023">8-isoprostane</z:chebi>) in diabetics vs. controls is distinct from and cannot be explained simply by differences in the burden of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> as assessed by carotid <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> </plain></SENT>
</text></document>